Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

I am a GILD shareholder but not surprised

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
I_luv_cydy Member Profile
 
Followed By 4
Posts 383
Boards Moderated 0
Alias Born 06/24/16
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 4:08:37 PM
Gilead Shows the Dangers of Covid-19 Drug Mania -- Heard on the Street Dow Jones News - 8/3/2020 7:29:00 AM
Gilead Swings to Quarterly Loss on Higher Costs -- Update Dow Jones News - 7/30/2020 8:27:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 6:58:48 PM
Gilead Swings to Quarterly Loss on Higher Costs Dow Jones News - 7/30/2020 5:33:00 PM
Gilead Revises Annual Guidance Dow Jones News - 7/30/2020 5:17:00 PM
Gilead Swings to 2Q Loss Following Acquisition and Manufacturing Expansion of Covid-19 Drug Remdesivir Dow Jones News - 7/30/2020 4:46:00 PM
Gilead Sciences Announces Third Quarter 2020 Dividend Business Wire - 7/30/2020 4:02:00 PM
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results Business Wire - 7/30/2020 4:01:00 PM
FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent Plasma -- Update Dow Jones News - 7/29/2020 5:33:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/28/2020 6:48:16 PM
Gilead Sciences & Satcher Health Leadership Institute at Morehouse School of Medicine Partner to Study Racial Health Inequiti... Business Wire - 7/28/2020 9:00:00 AM
U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Business Wire - 7/24/2020 1:25:00 PM
Gilead, Galapagos Say Arthritis Drug Gets Recommendation to Start Marketing in Europe Dow Jones News - 7/24/2020 9:14:00 AM
Gilead & Galapagos Announce Positive European CHMP Opinion for Jyseleca® (Filgotinib) for the Treatment of Adults With Moder... Business Wire - 7/24/2020 8:10:00 AM
Gilead Buying Initial 49.9% Stake in Tizona Therapeutics for $300 Million Dow Jones News - 7/21/2020 9:17:00 AM
Breakthroughs and Advancements in Pathogen Detection Offer Hope as Virus Cases Surge NetworkNewsWire - 7/21/2020 8:45:00 AM
Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million Business Wire - 7/21/2020 8:30:00 AM
Russian Hackers Blamed for Attacks on Vaccine-Related Targets -- Update Dow Jones News - 7/16/2020 5:41:00 PM
Gilead Sciences to Release Second Quarter 2020 Financial Results on Thursday, July 30, 2020 Business Wire - 7/16/2020 4:01:00 PM
Russian Hackers Blamed for Attacks on Vaccine-Related Targets -- Update Dow Jones News - 7/16/2020 1:18:00 PM
Glympse Bio Raises $46.7 Million in Series B Funding Round Dow Jones News - 7/15/2020 12:30:00 PM
Gilead Sciences & Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop & Co-Commercialize Next-Gener... Business Wire - 7/13/2020 4:05:00 PM
Gilead: Remdesivir Associated With Recovery, Reduction in Mortality Risk Dow Jones News - 7/10/2020 9:27:00 AM
Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19 Business Wire - 7/10/2020 8:30:00 AM
I_luv_cydy   Monday, 06/01/20 09:36:02 AM
Re: LionsTact post# 3925
Post # of 4309 
I am a GILD shareholder but not surprised on the bad news today on Remdesivir....
The REAL Covid solution will be known in the next 4-6 weeks...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist